Guidance for market authorization requirements for COVID-19 vaccines: Overview
This document provides guidance to vaccine manufacturers seeking authorization for their vaccine that targets the SARS-CoV-2 virus. This guidance applies to applications under the interim order respecting the importation, sale and advertising of drugs for use in relation to COVID-19.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Guidance for market authorization requirements for COVID-19 vaccines: OverviewHTMLEnglish publication HTML
-
Guidance for market authorization requirements for COVID-19 vaccines: OverviewHTMLFrench publication HTML